Complete financial analysis of National Research Corporation (NRC) income statement, including revenue, profit margins, EPS and key performance metrics. Get detailed insights into the financial performance of National Research Corporation, a leading company in the Medical – Healthcare Information Services industry within the Healthcare sector.
- Suvanza Pharma, LLC (SUVZ) Income Statement Analysis – Financial Results
- Trupanion, Inc. (TRUP) Income Statement Analysis – Financial Results
- Rejlers AB (publ) (REJL-B.ST) Income Statement Analysis – Financial Results
- PT FKS Multi Agro Tbk (FISH.JK) Income Statement Analysis – Financial Results
- Paradeep Phosphates Limited (PARADEEP.NS) Income Statement Analysis – Financial Results
National Research Corporation (NRC)
About National Research Corporation
National Research Corporation provides analytics and insights that facilitate measurement and enhancement of the patient and employee experience in the United States and Canada. Its portfolio of subscription-based solutions provides actionable information and analysis to healthcare organizations across a range of mission-critical, constituent-related elements, including patient experience, service recovery, care transitions, health risk assessments, employee engagement, reputation management, and brand loyalty. The company also offers market insights solutions that allow the tracking of awareness, perception, and consistency of healthcare brands; assessment of competitive differentiators; and enhanced segmentation tools to evaluate needs, wants, and behaviors of communities through real-time competitive assessments and enhanced segmentation tools. In addition, it provides experience solutions, such as patient and resident experience, workforce engagement, health risk assessments, transitions, and improvement tools. Further, the company offers health risk assessment solutions that enable clients to segment populations and manage care for those who are most at risk, engage individuals, enhance preventative care, and manage wellness programs; and transitions solutions, which enable organizations to identify and manage high-risk patients to reduce readmissions, enhance patient satisfaction and support safe care transitions. Additionally, it provides transparency solutions that allow healthcare organizations to share picture of their organization and ensure content informs in consumer decision-making; and governance solutions for not-for-profit hospital and health system boards of directors, executives, and physician leadership. The company serves integrated health systems, post-acute providers, and payer organizations. National Research Corporation was founded in 1981 and is headquartered in Lincoln, Nebraska.
| Metric | 2023 | 2022 | 2021 | 2020 | 2019 | 2018 | 2017 | 2016 | 2015 | 2014 | 2013 | 2012 | 2011 | 2010 | 2009 | 2008 | 2007 | 2006 | 2005 | 2004 | 2003 | 2002 | 2001 | 2000 | 1999 | 1998 | 1997 | 1996 | 1995 | 1994 | 1993 |
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
| Revenue | 148.58M | 151.57M | 147.95M | 133.28M | 127.98M | 119.69M | 117.56M | 109.38M | 102.34M | 98.84M | 92.59M | 86.42M | 75.77M | 63.40M | 57.69M | 51.01M | 48.92M | 43.77M | 32.44M | 29.68M | 26.92M | 22.39M | 17.67M | 18.32M | 18.20M | 17.70M | 16.30M | 12.60M | 8.92M | 6.76M | 2.81M |
| Cost of Revenue | 61.91M | 57.05M | 52.35M | 49.19M | 46.44M | 47.58M | 49.07M | 45.58M | 44.61M | 41.72M | 38.84M | 35.46M | 28.67M | 24.64M | 24.57M | 23.61M | 21.80M | 19.45M | 13.64M | 12.87M | 12.03M | 9.56M | 8.06M | 9.12M | 11.10M | 9.40M | 7.20M | 5.70M | 3.50M | 2.97M | 1.08M |
| Gross Profit | 86.67M | 94.52M | 95.60M | 84.09M | 81.55M | 72.11M | 68.49M | 63.81M | 57.73M | 57.12M | 53.75M | 50.96M | 47.10M | 38.76M | 33.12M | 27.40M | 27.12M | 24.33M | 18.79M | 16.81M | 14.89M | 12.83M | 9.61M | 9.20M | 7.10M | 8.30M | 9.10M | 6.90M | 5.42M | 3.79M | 1.73M |
| Gross Profit Ratio | 58.33% | 62.36% | 64.62% | 63.09% | 63.72% | 60.25% | 58.26% | 58.33% | 56.41% | 57.79% | 58.05% | 58.97% | 62.16% | 61.14% | 57.40% | 53.72% | 55.44% | 55.57% | 57.94% | 56.64% | 55.32% | 57.32% | 54.40% | 50.21% | 39.01% | 46.89% | 55.83% | 54.76% | 60.81% | 56.08% | 61.47% |
| Research & Development | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 |
| General & Administrative | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 31.37M | 29.69M | 28.39M | 27.18M | 25.02M | 25.21M | 23.54M | 23.30M | 20.20M | 15.59M | 12.73M | 13.17M | 12.16M | 8.62M | 7.39M | 5.99M | 4.74M | 4.99M | 4.60M | 4.20M | 4.80M | 4.00M | 0.00 | 0.00 | 0.00 | 0.00 |
| Selling & Marketing | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | -81.00 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 |
| SG&A | 46.58M | 42.70M | 38.96M | 34.44M | 32.97M | 31.37M | 29.69M | 28.39M | 27.18M | 25.02M | 25.21M | 23.54M | 23.30M | 20.20M | 15.59M | 12.73M | 13.17M | 12.16M | 8.62M | 7.39M | 5.99M | 4.74M | 4.99M | 4.60M | 4.20M | 4.80M | 4.00M | 3.10M | 2.36M | 2.04M | 1.17M |
| Other Expenses | 0.00 | 5.28M | 6.37M | 7.51M | 5.54M | 885.00K | 50.00K | 302.00K | 1.07M | 18.00K | 16.00K | -3.00K | 5.07M | 4.70M | 3.83M | 2.69M | 2.58M | 2.26M | 1.76M | 2.02M | 1.94M | 1.67M | 1.92M | 1.27M | 800.00K | 400.00K | 200.00K | 200.00K | 119.00K | 86.00K | 50.00K |
| Operating Expenses | 52.52M | 47.98M | 45.33M | 41.95M | 38.51M | 36.83M | 34.27M | 32.61M | 31.29M | 28.82M | 28.94M | 28.24M | 28.37M | 24.91M | 19.42M | 15.41M | 15.76M | 14.42M | 10.38M | 9.41M | 7.93M | 6.41M | 6.90M | 5.87M | 5.00M | 5.20M | 4.20M | 3.30M | 2.48M | 2.13M | 1.22M |
| Cost & Expenses | 108.54M | 105.03M | 97.68M | 91.13M | 84.95M | 84.41M | 83.34M | 78.19M | 75.90M | 70.54M | 67.78M | 63.70M | 57.03M | 49.54M | 44.00M | 39.02M | 37.56M | 33.86M | 24.02M | 22.28M | 19.96M | 15.97M | 14.96M | 14.99M | 16.10M | 14.60M | 11.40M | 9.00M | 5.98M | 5.10M | 2.30M |
| Interest Income | 820.00K | 168.00K | 14.00K | 18.00K | 37.00K | 62.00K | 96.00K | 47.00K | 60.00K | 83.00K | 63.00K | 32.00K | 13.00K | 6.00K | 2.00K | 42.00K | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 |
| Interest Expense | 862.00K | 1.21M | 1.67M | 1.81M | 2.09M | 1.51M | 82.00K | 190.00K | 220.00K | 305.00K | 397.00K | 541.00K | 629.00K | 491.00K | 405.00K | 139.00K | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 |
| Depreciation & Amortization | 5.90M | 5.28M | 6.37M | 7.51M | 5.54M | 5.46M | 4.59M | 4.23M | 4.11M | 3.80M | 3.73M | 4.70M | 5.07M | 4.70M | 3.83M | 2.69M | 2.58M | 2.26M | 1.76M | 2.02M | 1.94M | 1.67M | 1.92M | 1.27M | 800.00K | 400.00K | 200.00K | 200.00K | 119.00K | 86.00K | 50.00K |
| EBITDA | 45.99M | 51.83M | 56.66M | 50.79M | 48.15M | 41.69M | 38.95M | 35.77M | 31.69M | 32.20M | 28.62M | 27.45M | 23.85M | 18.51M | 17.35M | 14.72M | 13.95M | 12.17M | 10.18M | 9.42M | 8.91M | 8.09M | 4.63M | 4.59M | 2.90M | 3.50M | 5.10M | 3.80M | 3.06M | 1.74M | 561.00K |
| EBITDA Ratio | 30.95% | 34.22% | 38.30% | 37.70% | 37.62% | 34.83% | 33.13% | 32.70% | 30.96% | 32.58% | 30.91% | 31.76% | 31.43% | 29.29% | 30.39% | 28.85% | 28.31% | 27.93% | 31.40% | 31.75% | 32.76% | 36.45% | 26.31% | 25.29% | 18.13% | 32.20% | 39.26% | 28.57% | 34.29% | 25.82% | 19.96% |
| Operating Income | 40.05M | 46.54M | 50.27M | 42.68M | 43.04M | 35.28M | 34.22M | 31.20M | 26.45M | 28.30M | 24.81M | 22.72M | 18.74M | 13.86M | 13.70M | 11.99M | 11.37M | 9.91M | 8.42M | 7.40M | 6.97M | 6.42M | 2.71M | 3.32M | 2.10M | 3.10M | 4.90M | 3.60M | 2.94M | 1.66M | 511.00K |
| Operating Income Ratio | 26.95% | 30.71% | 33.98% | 32.02% | 33.63% | 29.47% | 29.11% | 28.52% | 25.84% | 28.63% | 26.79% | 26.29% | 24.73% | 21.86% | 23.74% | 23.50% | 23.23% | 22.64% | 25.94% | 24.94% | 25.87% | 28.67% | 15.35% | 18.15% | 11.54% | 17.51% | 30.06% | 28.57% | 32.96% | 24.54% | 18.18% |
| Total Other Income/Expenses | -83.00K | -3.73M | -1.65M | -1.21M | -2.52M | -566.00K | 64.00K | 159.00K | 913.00K | -204.00K | -318.00K | -512.00K | -575.00K | -542.00K | -580.00K | -6.00K | -248.16K | -402.10K | 99.00K | -118.79K | -49.00K | -257.64K | -88.57K | 531.54K | 100.00K | -2.30M | -1.30M | 200.00K | 108.00K | 46.00K | 12.00K |
| Income Before Tax | 39.96M | 42.82M | 48.62M | 41.47M | 40.52M | 34.71M | 34.28M | 31.36M | 27.36M | 28.09M | 24.49M | 22.21M | 18.16M | 13.32M | 13.12M | 11.98M | 11.12M | 9.51M | 8.51M | 7.28M | 6.92M | 6.16M | 2.62M | 3.86M | 2.20M | 800.00K | 3.60M | 3.80M | 3.05M | 1.70M | 523.00K |
| Income Before Tax Ratio | 26.90% | 28.25% | 32.86% | 31.11% | 31.66% | 29.00% | 29.16% | 28.67% | 26.73% | 28.42% | 26.45% | 25.70% | 23.97% | 21.00% | 22.74% | 23.49% | 22.72% | 21.72% | 26.25% | 24.54% | 25.69% | 27.52% | 14.85% | 21.05% | 12.09% | 4.52% | 22.09% | 30.16% | 34.17% | 25.23% | 18.61% |
| Income Tax Expense | 8.99M | 11.02M | 11.16M | 4.21M | 8.11M | 4.66M | 11.34M | 10.84M | 9.75M | 9.94M | 9.00M | 7.14M | 6.60M | 4.82M | 4.63M | 4.54M | 4.28M | 3.62M | 3.28M | 2.73M | 2.53M | 2.31M | 953.63K | 1.14M | 700.00K | 300.00K | 400.00K | 1.50M | 0.00 | 114.00K | 9.00K |
| Net Income | 30.97M | 31.80M | 37.47M | 37.26M | 32.41M | 30.05M | 22.94M | 20.52M | 17.61M | 18.16M | 15.48M | 15.07M | 11.56M | 8.50M | 8.49M | 7.45M | 6.84M | 5.88M | 5.24M | 4.55M | 4.38M | 3.85M | 1.67M | 2.72M | 1.50M | 500.00K | 3.20M | 2.30M | 3.05M | 1.59M | 514.00K |
| Net Income Ratio | 20.84% | 20.98% | 25.32% | 27.96% | 25.32% | 25.10% | 19.52% | 18.76% | 17.21% | 18.37% | 16.72% | 17.44% | 15.26% | 13.41% | 14.72% | 14.59% | 13.98% | 13.44% | 16.14% | 15.33% | 16.28% | 17.20% | 9.45% | 14.83% | 8.24% | 2.82% | 19.63% | 18.25% | 34.17% | 23.54% | 18.29% |
| EPS | 1.26 | 1.28 | 1.47 | 1.48 | 1.30 | 1.11 | 0.54 | 0.49 | 0.42 | 0.44 | 0.37 | 2.22 | 1.73 | 1.28 | 1.28 | 1.11 | 1.00 | 0.86 | 0.74 | 0.63 | 0.60 | 0.54 | 0.24 | 0.39 | 0.21 | 0.06 | 0.37 | 0.37 | 0.51 | 0.27 | 0.09 |
| EPS Diluted | 1.25 | 1.27 | 1.46 | 1.45 | 1.26 | 1.07 | 0.52 | 0.48 | 0.41 | 0.43 | 0.37 | 2.17 | 1.69 | 1.26 | 1.26 | 1.09 | 0.98 | 0.85 | 0.74 | 0.63 | 0.60 | 0.54 | 0.24 | 0.39 | 0.21 | 0.06 | 0.37 | 0.37 | 0.51 | 0.27 | 0.09 |
| Weighted Avg Shares Out | 24.54M | 24.92M | 25.42M | 25.17M | 24.81M | 27.09M | 24.28M | 24.22M | 24.22M | 24.24M | 24.12M | 6.78M | 6.67M | 6.64M | 6.64M | 6.69M | 6.84M | 6.84M | 7.08M | 7.22M | 7.31M | 7.13M | 6.96M | 6.97M | 7.14M | 8.33M | 8.65M | 6.22M | 6.00M | 6.00M | 6.00M |
| Weighted Avg Shares Out (Dil) | 24.67M | 25.05M | 25.64M | 25.70M | 25.65M | 28.08M | 25.23M | 24.60M | 24.50M | 24.61M | 24.61M | 6.95M | 6.84M | 6.74M | 6.72M | 6.83M | 6.98M | 6.92M | 7.08M | 7.28M | 7.31M | 7.16M | 7.09M | 7.06M | 7.50M | 8.33M | 8.65M | 6.22M | 6.00M | 6.00M | 6.00M |
Zacks Initiates Coverage of NRC Health With Neutral Recommendation
Signature Healthcare Elevates Patient Experience and Workforce Engagement Through Strategic Partnership With NRC Health
National Research Corporation Announces Third Quarter Results
National Research Corporation Announces Second Quarter Results
NANO Nuclear Energy Appoints Distinguished Nuclear Regulatory Expert David Tiktinsky as Head of Nuclear Regulatory Licensing after nearly 40-years with the Nuclear Regulatory Commission (NRC)
Top 5 Health Care Stocks That May Explode In July
ASML's secret sauce for semiconductor success amid challenges in the Angstrom Era
National Research Corporation (NRC) Q1 2024 Earnings Call Transcript
National Research Corporation Announces First Quarter Results
National Research Corporation to Broadcast Its First Quarter 2024 Conference Call Live on the Internet
Source: https://incomestatements.info
Category: Stock Reports